SMSLIFE — SMS Lifesciences India Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,608	2,656	3,497	3,156	3,060
Cost of Revenue
Gross Profit	663	837	976	946	1,024
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	2,432	2,433	3,256	2,976	2,898
Operating Profit	176	223	242	180	162
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	147	196	327	166	98.5
Provision for Income Taxes
Net Income After Taxes	102	136	253	114	63.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	102	136	253	115	90.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	102	136	253	115	90.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	33.6	44.8	63.5	32.6	30.1
Dividends per Share